Brokerages Set Tenet Healthcare Corporation (NYSE:THC) Target Price at $273.00

Shares of Tenet Healthcare Corporation (NYSE:THC) have been assigned an average recommendation of “Buy” from the twenty-one research firms that are presently covering the company, Marketbeat Ratings reports. One investment analyst has rated the stock with a hold rating, nineteen have issued a buy rating and one has given a strong buy rating to the company. The average 12 month price objective among brokerages that have issued a report on the stock in the last year is $273.00.

A number of analysts have recently commented on the company. TD Cowen boosted their price objective on Tenet Healthcare from $233.00 to $263.00 and gave the company a “buy” rating in a research report on Monday, July 27th. Mizuho set a $290.00 price target on shares of Tenet Healthcare in a research note on Monday, August 10th. Cantor Fitzgerald restated an “overweight” rating on shares of Tenet Healthcare in a research report on Monday, July 27th. Barclays lifted their target price on shares of Tenet Healthcare from $240.00 to $271.00 and gave the company an “overweight” rating in a research report on Friday, July 24th. Finally, Guggenheim upped their price target on shares of Tenet Healthcare from $242.00 to $283.00 and gave the stock a “buy” rating in a research report on Tuesday, July 28th.

Insiders Place Their Bets

In other Tenet Healthcare news, Director Christopher S. Lynch sold 3,837 shares of the firm’s stock in a transaction on Monday, July 27th. The stock was sold at an average price of $243.44, for a total value of $934,079.28. Following the transaction, the director owned 9,568 shares in the company, valued at approximately $2,329,233.92. This trade represents a 28.62% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Tammy Romo sold 4,922 shares of the company’s stock in a transaction on Thursday, August 6th. The stock was sold at an average price of $264.15, for a total transaction of $1,300,146.30. Following the sale, the director directly owned 30,784 shares of the company’s stock, valued at $8,131,593.60. The trade was a 13.78% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last 90 days, insiders have sold 41,375 shares of company stock valued at $9,793,347. 0.97% of the stock is owned by corporate insiders.

Institutional Trading of Tenet Healthcare

Several large investors have recently bought and sold shares of the business. denkapparat Operations GmbH lifted its stake in Tenet Healthcare by 37.6% in the 2nd quarter. denkapparat Operations GmbH now owns 3,716 shares of the company’s stock worth $695,000 after purchasing an additional 1,016 shares in the last quarter. Pale Fire Capital SE purchased a new stake in shares of Tenet Healthcare in the second quarter valued at approximately $374,000. Alamar Capital Management LLC increased its holdings in shares of Tenet Healthcare by 62.5% in the second quarter. Alamar Capital Management LLC now owns 18,062 shares of the company’s stock valued at $3,379,000 after purchasing an additional 6,950 shares during the last quarter. Nykredit A S purchased a new position in Tenet Healthcare during the second quarter worth approximately $600,000. Finally, Archer Investment Corp purchased a new stake in Tenet Healthcare in the 2nd quarter valued at $112,000. Hedge funds and other institutional investors own 95.44% of the company’s stock.

Tenet Healthcare Trading Up 2.9%

Shares of Tenet Healthcare stock opened at $280.60 on Monday. Tenet Healthcare has a fifty-two week low of $157.58 and a fifty-two week high of $280.89. The company has a debt-to-equity ratio of 2.00, a quick ratio of 1.35 and a current ratio of 1.41. The company has a market cap of $22.59 billion, a P/E ratio of 10.82, a price-to-earnings-growth ratio of 1.04 and a beta of 1.23. The firm has a 50-day simple moving average of $220.53 and a two-hundred day simple moving average of $206.80.

Tenet Healthcare (NYSE:THC) last announced its quarterly earnings results on Thursday, July 23rd. The company reported $6.12 earnings per share for the quarter, beating the consensus estimate of $4.26 by $1.86. The firm had revenue of $6.04 billion during the quarter, compared to analyst estimates of $5.43 billion. Tenet Healthcare had a return on equity of 26.76% and a net margin of 10.27%.Tenet Healthcare’s revenue for the quarter was up 6.8% compared to the same quarter last year. During the same quarter in the previous year, the business earned $4.02 EPS. Tenet Healthcare has set its FY 2026 guidance at 20.300-21.690 EPS. As a group, equities analysts predict that Tenet Healthcare will post 20.97 earnings per share for the current fiscal year.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.